The XmnI Gγ polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 β-thalassemia intermedia patients

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 2, 2010, Pages 124-127

  Nguyen, Thi Khanh Tien ^a   Joly, Philippe ^a   Bardel, Claire ^b   Moulsma, Mustapha ^c   Bonello Palot, Nathalie ^d   Francina Alain, A ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

BCL11A; Fetal hemoglobin; HBS1L MYB; Thalassemia intermedia; XmnI polymorphism

Indexed keywords

GENE PRODUCT; GUANINE; HEMOGLOBIN F; HYDROXYUREA; PROTEIN BCL 11A; PROTEIN HBS1L; PROTEIN MYB; PROTEIN XMNI; UNCLASSIFIED DRUG;

ARTICLE; BETA THALASSEMIA; CHROMOSOME ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEMOGLOBIN SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALPHA-GLOBINS; ANEMIA, SICKLE CELL; BETA-GLOBINS; CARRIER PROTEINS; COHORT STUDIES; FEMALE; FETAL HEMOGLOBIN; FRANCE; GENOTYPE; HUMANS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THALASSEMIA;

EID: 77955304167     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.04.002     Document Type: Article

References (42)

1. Weatherall D.J., Clegg J.B. Inherited haemoglobin disorders: an increasing global health problem. Bull. World Heath Org. 2001, 79:704-712.
2. Forget B.G. Molecular mechanisms of β-thalassaemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management 2001, 252-276. Cambridge University Press, Cambridge, U.K. M.H. Steinberg, B.G. Forget, D.R. Higgs, R.C. Nagel (Eds.).
3. Taher A.T., Isma'eel H., Cappellini M.D. Thalassaemia intermedia: revisited. Blood Cells Mol. Dis. 2006, 37:12-20.
4. Olivieri N.F., Weatherall D.J., D.J. Clinical aspects of β-thalassaemia and related disorders. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management 2009, 357-416. Cambridge University Press, Cambridge, U.K. M.H. Steinberg, B.G. Forget, D.R. Higgs, D.J. Weatherall (Eds.).
5. Thein S.L., Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br. J. Haematol. 2009, 145:455-467.
6. Labie D., Dunda-Belkhodja O., Rouabhi F., F., et al. The -158 site 5' to the G gamma gene and G gamma expression. Blood 1985, 66:1463-1465.
7. Sampietro M., Thein S.L., Contreras M., Pazmany L. Variation of HbF and F-cell number with the G-gamma XmnI (C-T) polymorphism in normal individuals. Blood 1992, 79:832-833.
8. Leonova J., Kazanetz E.G., Smetanina N.S., et al. Variability in the fetal hemoglobin level of the normal adult. Am. J. Hematol. 1996, 53:59-65.
9. Garner C., Mitchell J., J., Hatzis T., et al. Haplotype mapping of a major quantitative-trait locus for fetal haemoglobin production, on chromosome 6q23. Am. J. Hum. Genet. 1998, 62:1468-1474.
10. Thein S.L. Genetic modifiers of beta-thalassaemia. Haematologica 2005, 90:649-660.
11. Thein S.L., Menzel S., Peng X., et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl Acad. Sci. USA 2007, 104:11346-11351.
12. Wahlberg K., Jiang J., Rooks H., H., et al. The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 2009, 114:1254-1262.
13. Menzel S., Garner C., Gut I., et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 2007, 39:1197-1199.
14. Sedgewick A.E., Timofeev N., N., Sebastiani P., et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol. Dis. 2008, 41:255-258.
15. Lettre G., Sankaran V.G., Bezerra M.A., et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 2008, 105:11869-11874.
16. Uda M., Galanello R., R., Sanna S., et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassaemia. Proc. Natl Acad. Sci. USA 2008, 105:1620-1625.
17. Galanello R., Sanna S., Perseu L., et al. Amelioration of Sardinian beta-zero thalassaemia by genetic modifiers. Blood 2009, 114:3935-3937.
18. 2 and F. J. Clin. Pathol. 1993, 46:852-856.
19. Chong S.S., Boehm C.D., Higgs D.R., Cutting G.R. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood 2000, 95:960-962.
20. Dodé C., Rochette J., Krishnamoorty R. Locus assignment of human α-globin mutations by selective amplification and direct sequencing. Br. J. Haematol. 1990, 76:275-281.
21. anti3.7 triplication by enzymatic amplification analysis. Br. J. Haematol. 1993, 83:105-111.
22. Joly P., Lacan P., Garcia C., Couprie N., Francina A. Identification and molecular characterization of four new large deletions in the beta-globin gene cluster. Blood Cells Mol. Dis. 2009, 43:53-57.
23. Harteveld C.L., Voskamp A., Phylipsen M., et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J. Med. Genet. 2005, 42:922-931.
24. Lanclos K.D., Oner C., Dimovski A.J., et al. Sequence variations in the 5'flanking and IVS-II regions of the G gamma- and A gamma-globin genes of beta S chromosomes with five different haplotypes. Blood 1991, 77:2488-2496.
25. Pissard S., Beuzard Y. A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 1994, 84:331-338.
26. Liew M., Pryor R., Palais R., et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin. Chem. 2004, 50:1156-1164.
27. Allendorf F.W., Luikart G. Random mating populations: Hardy-Weinberg principle. Conservation and the Genetics of Populations 2007, 93-112. Blackwell Publishing, Malden, MA, USA. F.W. Allendorf, G. Luikart (Eds.).
28. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
29. Harteveld C.L., Refaldi C., Cassinerio E., et al. Segmental duplications involving the α-globin gene cluster are causing β-thalassaemia intermedia phenotypes in β-thalassaemia heterozygous patients. Blood Cells Mol. Dis. 2008, 40:312-316.
30. Badens C., Mattei M.G., Imbert A.M., et al. A novel mechanism of thalassaemia intermedia. Lancet 2002, 359:132-133.
31. +-thalassemia. Blood 2001, 98:1261-1263.
32. Menzel S., Jiang J., Silver N., et al. The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood 2007, 110:3624-3626.
33. Gilman J.G., Huisman T.H.J. DNA sequence variation associated with elevated fetal G gamma globin production. Blood 1985, 66:783-787.
34. Origa R., Galanello R., Ganz T., et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007, 92:583-588.
35. Wallrapp C., Verrier S.B., Zhouravleva G., et al. The product of the mammalian orthologue of the Saccharomyces cerevisiae HBS1 gene is phylogenetically related to eukaryotic release factor 3 (eRF3) but does not carry eRF3-like activity. FEBS Let. 1998, 440:387-392.
36. Jiang J., Best S., Menzel S., S., et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006, 108:1077-1083.
37. Vegiopoulos A., Garcia P., Emambokus N., Frampton J. Coordination of erythropoiesis by the transcription factor c-Myb. Blood 2006, 107:4703-4710.
38. Sankaran V.G., Menne T.F., Xu J., et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008, 322:1839-1842.
39. Chen Z., Luo H.Y., Steinberg M.H., Chui D.H. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol. Dis. 2009, 42:144-149.
40. Kanavaki I., Makrythanasis P., Lazaropoulou C., et al. Soluble endothelial adhesion molecules and inflammation markers in patients with β-thalassemia intermedia. Blood Cells Mol. Dis. 2009, 43:230-234.
41. Neishabury M., Azarkeivan A., Najmabadi H. Frequency of positive XmnI(G)gamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation. Blood Cells Mol. Dis. 2010, 44:95-99.
42. Thein S.L., Wood W.G. The molecular basis of β-thalassaemia, δβ-thalassaemia, and hereditary persistence of fetal haemoglobin. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management 2009, 323-356. Cambridge University Press, Cambridge, UK. M.H. Steinberg, B.G. Forget, D.R. Higgs, D.J. Weatherall (Eds.).